Hans de Haard

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Transforming Growth Factor

Top Venues

Nature communications

American journal of hematology

Neurology(R) neuroimmunology & neuroinflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J van der Kooi, Arthur E H Bentlage, Ninotska I L Derksen, Julie Andries, Bianca Balbino, Magdalena Sips, Peter Ulrichts, Peter Verheesen, Hans de Haard, Theo Rispens, Savvas N Savvides, Gestur Vidarsson
The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nature communications 13 (1) (2022)
Kevin Budding, Lill Eva Johansen, Inge Van De Walle, Kim Dijkxhoorn, Elisabeth de Zeeuw, Lauri M Bloemenkamp, Jeroen W Bos, Marc D Jansen, Chantall A D Curial, Karen Silence, Hans de Haard, Christophe Blanchetot, Liesbeth Van de Ven, Jeanette H W Leusen, Ronald Jeroen Pasterkamp, Leonard H van den Berg, C Erik Hack, Peter Boross, W Ludo van der Pol
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy. Neurology(R) neuroimmunology & neuroinflammation 9 (1) (2021)
Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon, Stéphanie Liénart, Orian Bricard, Sara Lecomte, Julien Devreux, Mélanie Gaignage, Gitte De Boeck, Lore Mariën, Inge Van De Walle, Bas van der Woning, Michael Saunders, Hans de Haard, Elien Vermeersch, Wim Maes, Hans Deckmyn, Pierre G Coulie, Nicolas van Baren, Sophie Lucas
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer. Nature communications 11 (1) (2020)
Adrian C Newland, Blanca Sánchez-González, László Rejtő, Miklos Egyed, Nataliya Romanyuk, Marie Godar, Katrien Verschueren, Domenica Gandini, Peter Ulrichts, Jon Beauchamp, Torsten Dreier, E Sally Ward, Marc Michel, Howard A Liebman, Hans de Haard, Nicolas Leupin, David J Kuter
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia. American journal of hematology 95 (2) (2019)